Kathleen Moore to Molecular Targeted Therapy
This is a "connection" page, showing publications Kathleen Moore has written about Molecular Targeted Therapy.
Connection Strength
0.813
-
Niraparib in the treatment of previously treated advanced ovarian, fallopian tubeĀ or primary peritoneal cancer. Future Oncol. 2020 Nov; 16(33):2701-2711.
Score: 0.653
-
Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study. Gynecol Oncol. 2020 09; 158(3):640-645.
Score: 0.160